| 11773082 |
CDK2 inhibitors |
Douglas C. Behenna, Robert Louis Hoffman, Asako Nagata, Sacha Ninkovic, Scott Channing Sutton |
2023-10-03 |
$498,891,000 |
| 11718603 |
CDK2 inhibitors |
Douglas C. Behenna, Robert Louis Hoffman, Asako Nagata, Sacha Ninkovic, Scott Channing Sutton |
2023-08-08 |
$554,183,000 |
| 11396512 |
CDK2/4/6 inhibitors |
Douglas C. Behenna, Ping Chen, Robert Louis Hoffman, Mehran Jalaie, Asako Nagata +5 more |
2022-07-26 |
$1,138,814,000 |
| 11203594 |
Anti-proliferative agents for treating PAH |
Samit Kumar Bhattacharya, Douglas C. Behenna, Kimberly O. Cameron, Ping Chen, John M. Curto +10 more |
2021-12-21 |
$2,121,061,000 |
| 11014911 |
CDK2 inhibitors |
Douglas C. Behenna, Robert Louis Hoffman, Asako Nagata, Sacha Ninkovic, Scott Channing Sutton |
2021-05-25 |
$425,301,000 |
| 10800783 |
CDK2/4/6 inhibitors |
Douglas C. Behenna, Ping Chen, Robert Louis Hoffman, Mehran Jalaie, Asako Nagata +5 more |
2020-10-13 |
$1,301,883,000 |
| 10450297 |
Sulfonyl amide derivatives for the treatment of abnormal cell growth |
Michael Joseph Luzzio, Samit Kumar Bhattacharya, Matthew Merrill Hayward, Catherine Angela Hulford, Christopher Lowell Autry +3 more |
2019-10-22 |
$864,920,000 |
| 10233188 |
CDK2/4/6 inhibitors |
Robert Louis Hoffman, Asako Nagata, Sacha Ninkovic |
2019-03-19 |
$456,507,000 |
| 8440822 |
Sulfonyl amide derivatives for the treatment of abnormal cell growth |
Michael Joseph Luzzio, Samit Kumar Bhattacharya, Matthew Merrill Hayward, Catherine Angela Hulford, Christopher Lowell Autry +3 more |
2013-05-14 |
|
| 8318762 |
Pyrazolospiroketone acetyl-CoA carboxylase inhibitors |
Jeffrey Corbett, Richard Elliott, David A. Griffith, Dennis Paul Phillion |
2012-11-27 |
$617,530,000 |
| 8247411 |
Sulfonyl amide derivatives for the treatment of abnormal cell growth |
Michael Joseph Luzzio, Samit Kumar Bhattacharya, Matthew Merrill Hayward, Catherine Angela Hulford, Christopher Lowell Autry +3 more |
2012-08-21 |
$625,854,000 |
| 7928109 |
Sulfonyl amide derivatives for the treatment of abnormal cell growth |
Michael Joseph Luzzio, Samit Kumar Bhattacharya, Matthew Merrill Hayward, Catherine Angela Hulford, Christopher Lowell Autry +3 more |
2011-04-19 |
$184,395,000 |
| 7119201 |
Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
Lawrence Alan Reiter |
2006-10-10 |
$197,936,000 |
| 6916807 |
Triaryl-oxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
Mark C. Noe |
2005-07-12 |
$283,397,000 |
| 6900201 |
N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
Mark C. Noe |
2005-05-31 |
$186,252,000 |
